Total Liabilities - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Epizyme Inc
Total Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
Total Liabilities
$284.4m
CAGR 3-Years
84%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Liabilities
$135.2B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
19%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities
$35.3B
CAGR 3-Years
-10%
CAGR 5-Years
-3%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Total Liabilities
$85B
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities
$5.4B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
19%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities
$7.9B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
22%

See Also

What is Epizyme Inc's Total Liabilities?
Total Liabilities
284.4m USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's Total Liabilities amounts to 284.4m USD.

What is Epizyme Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
39%

Over the last year, the Total Liabilities growth was 0%. The average annual Total Liabilities growth rates for Epizyme Inc have been 84% over the past three years , 39% over the past five years .

Back to Top